The structure-antituberculosis activity relationships study in a series of 5-aryl-2-thio-1,3,4-oxadiazole derivatives

dc.contributor.authorMacaev, Fliur
dc.contributor.authorRibkovskaia, Zinaida
dc.contributor.authorPogrebnoi, Serghei
dc.contributor.authorBoldescu, Veaceslav
dc.contributor.authorRusu, Ghenadie
dc.contributor.authorShvets, Nathaly
dc.contributor.authorDimoglo, Anatholy
dc.date.accessioned2025-10-29T11:30:13Z
dc.date.issued2011
dc.departmentGebze Teknik Üniversitesi
dc.description.abstractA series of 82 5-aryl-2-thio-1,3,4-oxadiazole derivatives were screened for their anti-mycobacterial activities against Mycobacterium tuberculosis H37Rv. The synthesized compounds 30-37 appeared to be the most active derivatives exhibiting more than 90% inhibition of mycobacterial growth at 12.5 mu g/mL. Structure-activity relationships study was performed for the given series by using the electronic-topological method combined with neural networks (ETM-NN). A system for the anti-mycobacterial activity prediction was developed as the result of training associative neural network (ASNN) with weights calculated from projections of a compound and each pharmacophoric fragment found on the elements of the Kohonen's self-organizing maps (SOMs). From the detailed analysis of all compounds under study, the necessary requirements for a compound to possess antituberculosis activity have been formulated. The analysis has shown that any requirement's violation for a molecule implies a considerable decrease or even complete loss of its activity. Molecular docking studies of the compounds allowed shedding light on the binding mode of these novel anti-mycobacterial inhibitors. (C) 2011 Elsevier Ltd. All rights reserved.
dc.description.sponsorshipUS Civilian Research and Development Foundation [MC2-3007]
dc.description.sponsorshipUS National Institutes of Health [N01-AI-95364]
dc.description.sponsorshipThe authors gratefully acknowledge funding through a grant from the Moldavian-US Bilateral Grants Program of the US Civilian Research and Development Foundation (Grant MC2-3007). We also acknowledge the Tuberculosis Antimicrobial Acquisition and Coordinating Facility provided through the US National Institutes of Health (Contract N01-AI-95364) for providing data on the antitubercular activity.
dc.identifier.doi10.1016/j.bmc.2011.09.038
dc.identifier.endpage6807
dc.identifier.issn0968-0896
dc.identifier.issn1464-3391
dc.identifier.issue22
dc.identifier.orcid0000-0003-2827-505X
dc.identifier.orcid0000-0002-3094-1990
dc.identifier.orcid0000-0003-0709-2086
dc.identifier.pmid22001325
dc.identifier.scopus2-s2.0-80054996638
dc.identifier.scopusqualityQ1
dc.identifier.startpage6792
dc.identifier.urihttps://doi.org/10.1016/j.bmc.2011.09.038
dc.identifier.urihttps://hdl.handle.net/20.500.14854/11452
dc.identifier.volume19
dc.identifier.wosWOS:000296535900029
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherPergamon-Elsevier Science Ltd
dc.relation.ispartofBioorganic & Medicinal Chemistry
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20251020
dc.subjectAntituberculosis activity
dc.subjectStructure-activity relationships
dc.subjectElectronic-topological method
dc.subjectNeural networks
dc.subjectDocking
dc.titleThe structure-antituberculosis activity relationships study in a series of 5-aryl-2-thio-1,3,4-oxadiazole derivatives
dc.typeArticle

Dosyalar